Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Sales | 291,199 | 271,725 | 264,660 | 267,859 | 254,141 |
| Cost of Goods | 175,626 | 169,995 | 162,398 | 160,749 | 158,636 |
| Gross Profit | 115,573 | 101,730 | 102,262 | 107,110 | 95,505 |
| Operating Expenses | 61,498 | 57,571 | 51,039 | 60,157 | 52,445 |
| Operating Income | 54,701 | 45,154 | 51,621 | 47,702 | 43,696 |
| Interest Expense | 4,346 | 4,907 | 6,107 | 4,618 | 3,794 |
| Other Income | 2,436 | 4,222 | 2,548 | 221 | 826 |
| Pre-tax Income | 52,791 | 44,469 | 48,062 | 43,305 | 40,728 |
| Income Tax | 15,310 | 12,568 | 15,489 | 9,870 | 11,811 |
| Net Income Continuous | 37,227 | 31,792 | 32,133 | 32,781 | 28,515 |
| Net Income Discontinuous | -464 | 3,397 | -48,739 | -7,032 | -128,630 |
| Net Income | $36,763 | $35,189 | $-16,606 | $25,749 | $-100,115 |
| EPS Basic Total Ops | 0.55 | 0.48 | -0.25 | 0.36 | -1.40 |
| EPS Basic Continuous Ops | 0.56 | 0.48 | 0.48 | 0.46 | 0.40 |
| EPS Basic Discontinuous Ops | -0.01 | 0.00 | -0.73 | -0.10 | -1.80 |
| EPS Diluted Total Ops | 0.54 | 0.45 | -0.24 | 0.36 | -1.37 |
| EPS Diluted Continuous Ops | 0.55 | 0.47 | 0.47 | 0.46 | 0.39 |
| EPS Diluted Discontinuous Ops | -0.01 | -0.01 | -0.72 | -0.10 | -1.76 |
| EBITDA(a) | $74,614 | $65,145 | $73,100 | $68,788 | $63,726 |